In U.S. Pat. No. 5,569,181 assigned to the same Assignee as the present invention, discussion was undertaken with regard to the problems arising from the potential cross-contamination that can occur with a multi-patent fluid dispensing system. One facet of the system provided involves prevention of contamination of the multi-use segment of the fluid path during the time the system is connected to the patient. The disclosed system utilized one of the two methods: a back flow preventing valve and a sterile filter, or a physical separation achieved by filling a dose container and separating the dose container from the filling fluid path before connection to the patient.
A back flow valve and a sterile filter combination should give sufficient protection. Bacteria cannot penetrate the filter. Viruses and proteins can penetrate the filter but are not active, and so cannot swim upstream. They can only diffuse. The drawbacks to this approach involve the pressure drop through the filter and volume of fluid remaining in the filter. Also, there is no way to verify that the filter is not leaking.
The present invention deals with additional methods of preventing contamination of the reusable fluid path by the patient being injected. To achieve the improved methods of preventing contamination, the present invention embodies the concept of preventing back flow, by providing no open fluid path through which bacteria can migrate or viruses or pyrogens can diffuse. (If a path is open, the velocity can then be made sufficient to prevent back diffusion.) Additionally, turbulence must be avoided since turbulence necessarily involves reverse flows and eddys that can carry material against the flow, unless the flow is high enough to prevent any part of the fluid from having a net upstream velocity vector.
Means of preventing contamination of the fluid path by contaminants other than the patient being injected are presented in U.S. Pat. No. 5,806,519. Any of the concepts presented there may be matched with any of the embodiments presented here. The relevant feature is the “per patient” connection.
It is a principal object of this invention to provide an improved apparatus for injecting a fluid medium into a plurality of patients while minimizing the chance of cross-contamination.
It is another object of this invention to provide an apparatus for injecting fluid mediums into patients in which there is no continuous stream of fluid existing between the source of the fluid and the patient.
It is another object of this invention to provide an apparatus in which a peristaltic apparatus is present which precludes the reverse flow of substances from the patient towards the origin of the fluid to be injected.
Other objects and advantages of this invention will be in part obvious and in part explained by reference to the accompanying specification and drawings in which:
a and 5b are diagrammatic illustrations of an apparatus in which there is a biased element to preclude reverse flow of fluid from the patient towards the source of medical fluid;
To better understand the present invention, reference is made to the drawings, and specifically to
This is a good strategy but it requires operator vigilance to make sure that the line is in the peristaltic device before being connected to the patient and that the rotary valve is moved before the line is removed from the peristaltic device. Interlocks and intermediate all/off positions on the rotary switch could be provided. The rotary valve could have a “no connection” position between each connection position. The interlocks could function such that the rotary valve cannot be moved to access an output line until the line is in the peristaltic device, and another interlock could require that the rotary valve be turned to the intermediate off before the tubing can be removed from the peristaltic pump.
The present apparatus includes an electronic control system (ECS) 40 to assure that the needs of the patient are met safely. ECS 40 gets information on the contents of the bulk reservoirs 10 and 11. The preferred method is to read bar codes indicated by numerals 10′ and 11′ respectively. Another way is to quiz the operator to enter the data each time a bulk reservoir is changed, and then store that information. The operator would read the label on or packaged with the bulk reservoir, and enter the appropriate data. This need only be done when a bulk reservoir is changed.
With each injection, the operator needs to tell the system what to do. The data most similar to present practice is: 1) the concentration desired, 2) the flow rate, and 3) the total volume to be delivered. Present practice also includes multiple phases with various flow rates during each phase. This system would allow various contrast concentrations during each flow rate as well.
However, given the capabilities of this system, a preferred set of information is: 1) the procedure being done, and 2) the patient weight. This way the contrast dose could be optimized for the patient. The algorithm would have been previously provided information on milligrams of iodine per kilogram of patient for each procedure when the system was first installed in the hospital. It could display concentration, flow rate and volume for operator verification, if the operator desired. An electronic interface 41 is shown which can connect to the hospital information system to get information on the patient, such as weight. Then the operator would only have to input the patient number. The electronic interface could also be connected to the imaging equipment. It could send or receive information so that, for instance, the operator only need to program the CT scanner with number of slices and body section, and this would be transmitted to the contrast delivery system to be used in determining flow rates and delays. The electronic interface would also be used to let the scanner trigger the contrast delivery system or vice versa, after the appropriate delays. A hard copy printer may be optionally part of the user interface, receiving data from the ECS. This can print a record of the actual injection for insertion into the patient records. The output may be alphanumeric or be a graphical representation of the injection.
The operation of delivering fluid to the patient can be started by the operator with a start switch on the contrast delivery system, or from the console of the scanner. There would need to be an arming procedure similar to that of present injectors to help assure patient safety.
In CT, usually only one injection is given, sometimes with pauses and changes in flow rates. As the end of the injection is reached, contrast can be conserved if the contrast flow is stopped and the diluent flow continued so the “bolus” of diluted contrast is flushed out of the tubing and into the patient. In angiography, several injections may be used. It is necessary to flush only after the last injection, although no harm, except injecting a little extra fluid, occurs if the flush follows each injection.
Another form of waste is using contrast to prime the fluid path which is disposed of with each patient, especially if the concentration has not yet been decided upon. The flush or diluent fluid is much cheaper than the contrast and of lower viscosity, so it can be used to prime the line and make sure that all air has been removed from the path to the patient.
Referring to
The peristaltic mechanism could be used as a flow sensor. It could be coupled to a shaft on the durable equipment or an optical sensor could detect when the gears pass. Another use of the peristaltic flow sensor is as a mechanical stop. Peristaltic flow sensor could be placed on the durable equipment in such a way that the ECS 40 read the number of revolutions and stop its rotation when the appropriate volume was reached. Because the peristaltic flow sensor has some friction, it also prevents flow through caused by gravity when the system is off. The integral disposable peristaltic mechanism would limit dripping when the “per patient” disposable is removed. This “per patient” disposable peristaltic pump would also be a convenient pumping means for other low pressure IV fluid injections.
In all the peristaltic mechanisms above, any type of peristaltic motion is acceptable. A linear peristaltic mechanism would work. Two lines may be run in parallel through out of phase peristaltic mechanisms and their outputs combined to significantly decrease pulsations.
Also, it is important to note that a peristaltic mechanism while effective is not sufficient to prevent cross-contamination, if turned backwards, either by operator action or by back pressure, for example. There should be back flow prevention means in the line, or preferably in the peristaltic mechanism itself.
In another embodiment, see specifically
It may be that redundancy is achieved by having several conical blockers in series, or conical blocker in series with a peristaltic blocker. These could be combined with sterile filters or with air gaps as set forth below. While any one can be sufficient alone, the combinations may be needed to satisfy the perceptions of the patients or hospital personnel.
Referring to
Present hospital practice uses drip chambers, in which fluid drips through air. They are used with most IV injections. These drip chambers are designed for flow measuring. They are part of single use disposable devices and so have no relation to cross-contamination prevention.
Present art also included disposable burettes (
In operation, the fluid injector is armed. When the start button is depressed, the metering pumps (not shown) start immediately. Mixed fluid flows into the top of the cone and collects at the bottom. This continues until several milliliters has collected in the cone and funnel geometry. The exact amount depends upon the programmed flow rate. The size of the cone needs to be sufficient to contain at least one second's worth of fluid at the programmed flow rate. After pre-filling the cone, the pressurizing pump is started. It pulls fluid from the cone and injects it into the patient. For low pressure applications, the pressurizing pump could be a peristaltic pump. For higher pressures, it preferably is a gear pump, although other types would do. Because the fluid contacting part is disposable, the gear head would be plastic, probably polycarbonate, and would mate to the durable equipment and be turned by it.
If there is air in the funnel, then there needs to be a fluid assurance device 22 at the outlet tube of the funnel, so that if something fails and the funnel is not filled, the ECS to can stop the pressurizing pump 25, preventing air from being pulled from the funnel and being delivered to the patient. There could also be a second fluid assurance after the pressurizing pump for redundance. This would be especially useful for intra-arterial injections where air injection has much more serious consequence than during IV injections.
A second embodiment for the class of blocking means forming a break in the fluid stream uses a collapsible bag 75, as shown in
As with the funnel, the bag needs to be made from hydrophobic material such as polypropylene so that no continuous stream of fluid remains after flow is stopped. The flow entering the bag needs to be slowed by choice of inlet diameter and tangential path so that it adheres to the wall and no splashing occurs.
While not ideal, it is possible to eliminate the static mixer by filling the bag, providing ultrasonic agitation and then pumping the mixture out. This is not as desirable because concentration cannot be changed during delivery.
By properly sizing the funnel or the bag, the need for a back flow preventer is eliminated. If the total volume of the fluid path down stream from the funnel or bag is less than the volume required to fill the funnel or bag, then back flow can never breach the air gap. If the funnel or bag volume is less than the down stream fluid path volume, then a back flow valve is needed.
It is also important that the funnel or bag be held in the proper upright position during use, since gravity is being used to assure that air surround the inlet port.
This application is a continuation of U.S. application Ser. No. 09/575,809 (U.S. Pat. No. 6,306,117) filed May. 22, 2000, which is a continuation of U.S. application Ser. No. 09/102,554 (U.S. Pat. No. 6,149,627) filed Jun. 23, 1998, which is a continuation of U.S. application Ser. No. 08/755,755 (U.S. Pat. No. 5,843,037) filed Oct. 21, 1996, which is a continuation of U.S. application Ser. No. 08/144,460 (abandoned) filed Oct. 28, 1993, each of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3349713 | Fassbender | Oct 1967 | A |
3523523 | Reich | Aug 1970 | A |
3623474 | Heilman et al. | Nov 1971 | A |
3701345 | Heilman | Oct 1972 | A |
3755655 | Sewecal | Aug 1973 | A |
3793600 | Groubard | Feb 1974 | A |
3812843 | Wjutten | May 1974 | A |
3888239 | Rubenstein | Jun 1975 | A |
3895220 | Nelson | Jul 1975 | A |
3898983 | Elam | Aug 1975 | A |
3927955 | Spinosa | Dec 1975 | A |
3941126 | Dietrich | Mar 1976 | A |
3958103 | Oka | May 1976 | A |
3968195 | Bishop | Jul 1976 | A |
3995381 | Manfred | Dec 1976 | A |
4001549 | Corwin | Jan 1977 | A |
4038981 | LeFevre | Aug 1977 | A |
4090502 | Tajika | May 1978 | A |
4151845 | Clemens | May 1979 | A |
4187057 | Xanthopoulos | Feb 1980 | A |
4191183 | Mendelson | Mar 1980 | A |
4199000 | Edstrom | Apr 1980 | A |
4207871 | Jenkins | Jun 1980 | A |
4223675 | Williams | Sep 1980 | A |
4262824 | Hrynewycz | Apr 1981 | A |
4280494 | Cosgrove | Jul 1981 | A |
4284073 | Krause | Aug 1981 | A |
4319568 | Tregouing | Mar 1982 | A |
4340153 | Spivey | Jul 1982 | A |
4341153 | Bowser | Jul 1982 | A |
4392849 | Petre | Jul 1983 | A |
4396385 | Kelly | Aug 1983 | A |
4402310 | Kimura | Sep 1983 | A |
4409966 | Lambrecht et al. | Oct 1983 | A |
4434822 | Bellamy | Mar 1984 | A |
4444198 | Petre | Apr 1984 | A |
4447230 | Gula | May 1984 | A |
4479760 | Bilstad | Oct 1984 | A |
4479761 | Bilstad | Oct 1984 | A |
4479762 | Bilstad | Oct 1984 | A |
4512764 | Wunsch | Apr 1985 | A |
4544949 | Kurihara | Oct 1985 | A |
4551133 | Zegers de Beyl | Nov 1985 | A |
4559036 | Wunsch | Dec 1985 | A |
4563175 | LaFond | Jan 1986 | A |
4585009 | Barker | Apr 1986 | A |
4585941 | Bergner | Apr 1986 | A |
4610670 | Spencer | Sep 1986 | A |
4610790 | Reti | Sep 1986 | A |
4633307 | Honda | Dec 1986 | A |
4634426 | Kamen | Jan 1987 | A |
4636144 | Abe | Jan 1987 | A |
4655197 | Atkinson | Apr 1987 | A |
4662906 | Matkovich | May 1987 | A |
4682170 | Kubata | Jul 1987 | A |
4710166 | Thompson et al. | Dec 1987 | A |
4750643 | Wortrich | Jun 1988 | A |
4754786 | Roberts | Jul 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4781687 | Wall | Nov 1988 | A |
4783273 | Knutsson | Nov 1988 | A |
4798590 | O'Leary | Jan 1989 | A |
4823833 | Hogan | Apr 1989 | A |
4835521 | Andrejasich | May 1989 | A |
4836187 | Iwakoshi et al. | Jun 1989 | A |
4838856 | Mulreany et al. | Jun 1989 | A |
4840620 | Kobayashi | Jun 1989 | A |
4844052 | Iwakoshi et al. | Jul 1989 | A |
4853521 | Claeys | Aug 1989 | A |
4854301 | Nakajima | Aug 1989 | A |
4854324 | Hirschman | Aug 1989 | A |
4857056 | Talonn | Aug 1989 | A |
4874359 | White et al. | Oct 1989 | A |
4879880 | Harrison | Nov 1989 | A |
4880014 | Zarowitz | Nov 1989 | A |
4887208 | Schneider | Dec 1989 | A |
4887554 | Whitford | Dec 1989 | A |
4925444 | Orkin et al. | May 1990 | A |
4929818 | Bradbury | May 1990 | A |
4935005 | Haines | Jun 1990 | A |
4936832 | Vaillancourt | Jun 1990 | A |
4943279 | Samiotes | Jul 1990 | A |
4946439 | Eggers | Aug 1990 | A |
4950245 | Brown | Aug 1990 | A |
4954129 | Giuliani et al. | Sep 1990 | A |
4976687 | Martin | Dec 1990 | A |
4978335 | Arthur | Dec 1990 | A |
4981467 | Bobo | Jan 1991 | A |
5004472 | Wallace | Apr 1991 | A |
5009654 | Minshall | Apr 1991 | A |
5032112 | Fairchild | Jul 1991 | A |
5053002 | Barlow | Oct 1991 | A |
5059173 | Sacco | Oct 1991 | A |
5061243 | Winchell et al. | Oct 1991 | A |
5078683 | Sancoff | Jan 1992 | A |
5088981 | Howson | Feb 1992 | A |
5100380 | Epstein | Mar 1992 | A |
5104374 | Bisko et al. | Apr 1992 | A |
5104387 | Pokorney et al. | Apr 1992 | A |
5108365 | Woods, Jr. | Apr 1992 | A |
5113904 | Aslanian | May 1992 | A |
5128121 | Berg | Jul 1992 | A |
5133336 | Savitt et al. | Jul 1992 | A |
5135000 | Kami et al. | Aug 1992 | A |
5163909 | Stewart | Nov 1992 | A |
5180896 | Gibby | Jan 1993 | A |
5191878 | Iida et al. | Mar 1993 | A |
5196007 | Ellman et al. | Mar 1993 | A |
5199604 | Palmer | Apr 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5230614 | Zanger | Jul 1993 | A |
5242390 | Goldrath | Sep 1993 | A |
5267174 | Kaufman | Nov 1993 | A |
5269756 | Dryden | Dec 1993 | A |
5273537 | Haskvitz | Dec 1993 | A |
5274218 | Vata | Dec 1993 | A |
5310997 | Roach | May 1994 | A |
5313992 | Grabenkort | May 1994 | A |
5317506 | Coutre | May 1994 | A |
5328463 | Barton | Jul 1994 | A |
5329459 | Kaufman | Jul 1994 | A |
5339799 | Kami | Aug 1994 | A |
5349625 | Born | Sep 1994 | A |
5354273 | Hagen | Oct 1994 | A |
5361761 | Van Lysel | Nov 1994 | A |
5362948 | Mormoto | Nov 1994 | A |
5368562 | Blomquist | Nov 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5378231 | Johnson | Jan 1995 | A |
5382232 | Hauge et al. | Jan 1995 | A |
5385540 | Abbott | Jan 1995 | A |
5417213 | Prince | May 1995 | A |
5431627 | Pastrone | Jul 1995 | A |
4946256 | Kumble | Aug 1995 | A |
5445621 | Poli | Aug 1995 | A |
5450847 | Kampfe et al. | Sep 1995 | A |
5458128 | Polanyi | Oct 1995 | A |
5460609 | O'Donnell | Oct 1995 | A |
5464391 | DeVale | Nov 1995 | A |
5468240 | Genetelia et al. | Nov 1995 | A |
5472403 | Comacchia et al. | Dec 1995 | A |
5474683 | Bryant | Dec 1995 | A |
5485831 | Holdsworth | Jan 1996 | A |
5489265 | Montalvo | Feb 1996 | A |
5494036 | Uber, III | Feb 1996 | A |
5494822 | Sadri | Feb 1996 | A |
5496273 | Pastrone | Mar 1996 | A |
5507412 | Ebert | Apr 1996 | A |
5515851 | Goldstein | May 1996 | A |
5522798 | Johnson | Jun 1996 | A |
5531679 | Schulman | Jul 1996 | A |
5531697 | Olsen | Jul 1996 | A |
5533978 | Teirstein | Jul 1996 | A |
5547470 | Johnson | Aug 1996 | A |
5552130 | Kraus | Sep 1996 | A |
5553619 | Prince | Sep 1996 | A |
5560317 | Bunyan et al. | Oct 1996 | A |
5569208 | Woelpper | Oct 1996 | A |
5573515 | Wilson | Nov 1996 | A |
5579767 | Prince | Dec 1996 | A |
5590654 | Prince | Jan 1997 | A |
5592940 | Kampfe et al. | Jan 1997 | A |
5616124 | Hague | Apr 1997 | A |
5768405 | Markam-Ebeid | Jun 1998 | A |
5799649 | Prince | Sep 1998 | A |
5800397 | Wilson | Sep 1998 | A |
5806519 | Evans et al. | Sep 1998 | A |
5840026 | Uber, III et al. | Nov 1998 | A |
5843037 | Uber, III | Dec 1998 | A |
5882343 | Wilson | Mar 1999 | A |
5885216 | Evans, III et al. | Mar 1999 | A |
5916165 | Duchon | Jun 1999 | A |
5988587 | Duchon | Nov 1999 | A |
6099502 | Duchon | Aug 2000 | A |
6149627 | Uber, III | Nov 2000 | A |
6221045 | Duchon et al. | Apr 2001 | B1 |
6306117 | Uber, III | Oct 2001 | B1 |
6344030 | Duchon et al. | Feb 2002 | B1 |
6385483 | Uber et al. | May 2002 | B1 |
6442418 | Evans, III et al. | Aug 2002 | B1 |
6626862 | Duchon et al. | Sep 2003 | B1 |
6656157 | Duchon et al. | Dec 2003 | B1 |
20030050556 | Uber, III et al. | Mar 2003 | A1 |
20040015078 | Evans, III et al. | Jan 2004 | A1 |
Number | Date | Country |
---|---|---|
2045070 | Feb 1992 | CA |
3726452 | Jan 1989 | DE |
41 21 568 | Oct 1992 | DE |
41 21 568 | Oct 1992 | DE |
44 26 387 | Aug 1995 | DE |
0 189 491 | Aug 1986 | EP |
0 337 924 | Oct 1989 | EP |
0343501 | Nov 1989 | EP |
0 600 448 | Jun 1994 | EP |
0 619 122 | Oct 1994 | EP |
0 650 738 | May 1995 | EP |
0 650 739 | May 1995 | EP |
0 702 966 | Mar 1996 | EP |
2492708 | May 1982 | FR |
2561949 | Oct 1985 | FR |
2 207 749 | Feb 1989 | GB |
2252656 | Aug 1992 | GB |
WO 8001754 | Sep 1980 | WO |
WO 8500292 | Jan 1985 | WO |
WO 8803815 | Jun 1988 | WO |
WO 9415664 | Jul 1994 | WO |
WO 9632975 | Oct 1996 | WO |
WO 9924095 | May 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20020026148 A1 | Feb 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09575809 | May 2000 | US |
Child | 09939656 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09102554 | Jun 1998 | US |
Child | 09575809 | US | |
Parent | 08755755 | Oct 1996 | US |
Child | 09102554 | US | |
Parent | 08144460 | Oct 1993 | US |
Child | 08755755 | US |